Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00020046
Recruitment Status : Completed
First Posted : March 5, 2007
Last Update Posted : March 15, 2012
Information provided by:
National Institutes of Health Clinical Center (CC)